3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
 
MMTC15_Header  
MMTC M Header 

Cambridge Healthtech Institute’s Fifth Annual

Circulating Tumor Cells

Future of Cancer Management

February 15-18, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd Annual Molecular Medicine Tri-Conference

 

Circulating biomarkers continue to dominate cancer research by detecting the elusive signature in blood, serum or plasma. Isolation and characterization of circulating tumor cells and cell-free DNA enable the precise diagnosis and monitoring of cancer but significant challenges remain in validating methods for clinical use. This conference will showcase advances in technology and clinical applications and ultimately decide which will be the most robust technologies for personalized cancer care.

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields of R&D, Oncology, Cell Biology, Chemistry and Biotechnology.

Topics will include, but are not limited to: 

  • NGS of single cells
  • Clinical studies supporting cancer management using CTCs
  • Comparison of CTCs with cell-free DNA
  • Single cell analysis on CTCs
  • In vivo isolation of CTCs
  • Molecular single cell genomic profiling
  • Proteomic profiling and signaling pathways
  • Mechanical measurements in single cells
  • Using CTCs as companion diagnostic
  • Improvements in detection and isolation
  • Clinical validation process
  • CTC-based diagnostic platforms

If you would like to submit a proposal to give a presentation at this meeting, please click here.  

The deadline for submission is July 18, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464
E:  clingham@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 

 

 



Premier Sponsors:

Leica Biosystems 
 

 NanoString2   

 

Singulex 

 

Jackson Laboratory - small logo